Health and Human Services Secretary Robert F. Kennedy Jr. is navigating pressures from his Make America Healthy Again (MAHA) base while working inside the White House — and he says he will not run for president in 2028. In a May 7 interview with KFF Health News, Kennedy was asked whether he sees a path to run again as a Republican and answered bluntly: “No, I’m not going to run.” The story was published May 15, 2026.
Kennedy is traveling and speaking to voters as part of a recent northern Ohio tour and is expected to stump for Republican candidates in competitive midterm races. His appearances are aimed at shoring up GOP support, but they also highlight the tension he faces: MAHA supporters want him to press harder on priorities such as limiting vaccines, restricting certain chemicals and pesticides, and investigating fringe claims, while the White House has signaled a desire that he step back from the most controversial anti-vaccine rhetoric.
That split surfaced at a recent Cleveland City Club event, where Kennedy’s calls for more parental “choice” on vaccinating children drew both applause and audible dissent. Some MAHA adherents say they feel betrayed by White House decisions they see as undermining the movement’s agenda, and they want Kennedy to do more. Others hope he might launch another presidential bid — a move he has now ruled out.
The White House has taken several actions that have frustrated MAHA supporters. In April, President Trump nominated Erica Schwartz, a vaccine supporter, to lead the Centers for Disease Control and Prevention; Kennedy had previously dismissed CDC director Susan Monarez, who testified she was ousted for not preapproving vaccine recommendations. Trump also withdrew wellness influencer Casey Means’ nomination for U.S. surgeon general and later nominated Nicole Saphier, a more mainstream medical figure. Those choices, and White House efforts to steer Kennedy away from vaccine attacks, have fed criticism among Kennedy loyalists who expected stronger MAHA influence.
Kennedy rejects the notion that the administration has tied his hands. He said President Trump has allowed him “to do more than any HHS secretary in history,” and he has publicly expressed support for Saphier even as MAHA influencers criticized the nomination. Still, allies and activists argue that certain White House moves — along with administration rollbacks of environmental protections and support for pesticides — have disappointed MAHA voters who hoped for more sweeping policy changes.
Outside analysts say Kennedy’s presence in the administration matters for the movement. David Mansdoerfer, who served as deputy assistant secretary for health in the first Trump administration, warned that MAHA influence would diminish if Kennedy left HHS. Northeastern professor Christopher Bosso said a run would be a logical next step for Kennedy, though Kennedy says he will not pursue it.
Politically, Kennedy’s appeal remains concentrated within the MAHA constituency. A March straw poll at CPAC found almost no support for him as a presidential candidate among attendees, and some experts say MAHA’s base may be less likely to translate into broader primary or general-election votes. Still, polls cited by KFF show MAHA identifies strongly with a sizable segment of the electorate — about a third in one survey — and vaccine policy is an important issue for many voters. A separate KFF Health News poll in April found 81% of voters said vaccine policy would influence their vote in the 2026 midterms.
In response to the political dynamics, Kennedy has shifted some public priorities. He has downplayed vaccines in favor of issues that poll well, such as healthcare affordability, drug prices and nutrition. In recent congressional testimony and public statements he emphasized lowering costs, redesigning nutritional guidelines and pressing industry over certain food dyes, while largely avoiding the more contentious topics that defined his early months in office.
MAHA activists remain divided over whether staying inside the administration or pursuing an independent political path would better advance their goals. Some supporters, like activist Stephanie Weidle, want Kennedy to run again. Others see White House nominees and policy choices as evidence that the movement’s influence is being constrained even with Kennedy in HHS. For now, Kennedy is focused on balancing those competing pressures from inside the administration and on the campaign trail — and he says he won’t be a 2028 candidate.